ClinicalTrials.gg
Not yet recruitingNCT06929221Updated Oct 1, 2025

The Effect of Bedside Whiteboard Use on Anxiety, Depression and Nursing Care in Chronic Obstructive Pulmonary Patients

An interventional study of use of whiteboard in COPD and Nursing Care, sponsored by Agri Ibrahim Cecen University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Agri Ibrahim Cecen University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

ABSTRACT Chronic obstructive pulmonary disease (COPD) is a disease characterized by the inability of the body to adequately exchange gases, resulting in progressive shortness of breath that can form secretions and compromise the performance of daily activities. COPD is reported as the third most common cause of death worldwide, with 3.23 million deaths in 2019. Anxiety and depression are common in individuals with COPD. However, COPD is more common in patients with other chronic diseases such as hypertension, diabetes, cancer or musculoskeletal disorders. Communication is a key component in interprofessional care as well as in improving patient care outcomes. Strategies to address gaps in the quality of information and communication between patients, caregivers and professionals improve patient safety as well as quality of care. One of these strategies is the use of whiteboards at the bedside. The use of whiteboards at the bedside has emerged as a strategy to improve interprofessional team participation, communication and information sharing with care teams, patients and families. This study will be conducted in randomized controlled single blind parallel groups to examine the effect of bedside whiteboard use on anxiety, depression and nursing care satisfaction in COPD patients. The research will consist of patients who are hospitalized in Atatürk University Research Hospital Chest Diseases Clinic and who meet the inclusion criteria. In the results of the research, it is thought that the use of whiteboard will affect the communication between health care team members.

02

Conditions studied

  • COPD
  • Nursing Care
03

In context

Pulmonary Disease, Chronic Obstructive

5,520 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.

This study's planned enrollment of 128 is above the median of 62 across 3,839 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Agri Ibrahim Cecen University is the lead sponsor of 40 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • Having a medical diagnosis of
  • To be in a condition to be followed up with at least 7 days

Exclusion criteria

Exclusion Criteria:

  • - Having strong reading and comprehension skills
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Whiteboard group

    Other: use of whiteboard

  • No intervention
    Control Group

Interventions

  • Otheruse of whiteboard

    Patients will be followed up for 7 days. Routine nursing care will be applied to the control group. The following information will be included on the whiteboard fixed in the patient room for the intervention group. * Nurse's name * Doctor's name * Treatment times during the day * Nursing interventions and hours for the diagnoses considered for the patient's major problems * Timing of diagnostic and imaging techniques to be performed on the patient * Content of appropriate discharge education for the patient * Points to be considered by the patient before and after treatment * Dietary considerations for the patient * Nurse and patient's private note As a result of the data obtained, statistical analyses will be performed and interpreted to determine the effect of whiteboard use on anxiety, depression and satisfaction with nursing care in COPD patients.

06

What researchers measure

Primary outcomes

  1. How does the use of whiteboard affect anxiety, depression and nursing care satisfaction in COPD patients?

    The Hospital Anxiety and Depression Scale will be used to examine the effect of the whiteboard to be used for COPD patients on anxiety and depression. A total scale score of 28 and above indicates a high level of anxiety and depression.

    Time frame: From registration until the end of the 3th month

  2. How does the use of whiteboard affect anxiety, depression and nursing care satisfaction in COPD patients?

    The Patient Satisfaction with Nursing Care Quality Questionnaire Scale will be used to examine the effect of the whiteboard to be used for COPD patients on nursing satisfaction. A total score of 47.5 and above indicates high nursing care satisfaction.

    Time frame: From registration until the end of the 3th month

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06929221
Lead sponsor
Agri Ibrahim Cecen University
Responsible party
Ramazan DENİZ (Principal Investigator, Agri Ibrahim Cecen University) — Principal investigator
First posted
Apr 16, 2025
Start date
Dec 15, 2025 (estimated)
Primary completion
Apr 15, 2026 (estimated)
Completion
Jul 15, 2026 (estimated)
Last update
Oct 1, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion